back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2021-12-13 15:31 Tx date 2021-12-07 |
$LOVE
Cannara Biotech Inc. |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,000
+50,000 vol $0.18 each |
150,000 | |
| Filed 2020-02-28 11:59 Tx date 2019-04-25 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,000
+100,000 vol $0.18 each |
100,000 | |
| Filed 2020-02-28 11:58 Tx date 2019-04-08 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-02-28 11:58 Tx date 2020-02-04 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$155,000
+1,000,000 vol $0.155 each |
2,190,000 | |
| Filed 2020-02-28 11:55 Tx date 2020-02-03 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,450
+190,000 vol $0.155 each |
1,190,000 | |
| Filed 2020-02-28 11:54 Tx date 2020-02-03 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$165,000
+1,000,000 vol $0.165 each |
1,000,000 | |
| Filed 2020-02-28 11:54 Tx date 2019-12-27 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-115,862.50
-1,007,500 vol $0.115 each |
0 | |
| Filed 2020-02-28 11:53 Tx date 2019-12-24 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,720
-31,000 vol $0.12 each |
1,007,500 | |
| Filed 2020-02-28 11:53 Tx date 2019-12-23 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-8,280
-69,000 vol $0.12 each |
1,038,500 | |
| Filed 2020-02-28 11:52 Tx date 2019-12-20 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-43,500
-362,500 vol $0.12 each |
1,107,500 | |
| Filed 2020-02-28 11:52 Tx date 2019-12-19 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-164,920
-1,330,000 vol $0.124 each |
1,470,000 | |
| Filed 2020-02-28 11:51 Tx date 2019-04-08 |
$LOVE
Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) |
Kay, Jack M.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,800,000 |